Five-year change in statistical designs of phase II trials published in leading cancer journalsTHEZENAS, S; DUFFOUR, J; CULINE, S et al.European journal of cancer (1990). 2004, Vol 40, Num 8, pp 1244-1249, issn 0959-8049, 6 p.Article

The value of endoscopic rectal ultrasoud in predicting the lateral clearance an outcome in p atients with lower-third rectal adenocarcinomaASSENAT, E; THEZENAS, S; SAMALLN, E et al.Endoscopy (Stuttgart). 2007, Vol 39, Num 4, pp 309-313, issn 0013-726X, 5 p.Article

Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopausePUJOL, P; DAURES, J.-P; THEZENAS, S et al.Cancer. 1998, Vol 83, Num 4, pp 698-705, issn 0008-543XArticle

Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trialSAMALIN, E; BOUCHE, O; GALAIS, M. P et al.British journal of cancer. 2014, Vol 110, Num 5, pp 1148-1154, issn 0007-0920, 7 p.Article

Étude de faisabilité de radiothérapie de conformation avec modulation d'intensité dans les cancers localisés de la prostate = Pilot study of conformal intensity modulated radiation therapy for localized prostate cancer = Modulation d'intensité ; cancer de la prostate ; radiothérapieAILLERES, N; AZRIA, D; THEZENAS, S et al.Cancer radiothérapie. 2004, Vol 8, Num 2, pp 59-69, issn 1278-3218, 11 p.Article

A Weekly schedule of Docetaxel for metastatic hormone-refractory prostate cancerFERRERO, J. M; FOA, C; CHEVALLIER, D et al.Oncology. 2004, Vol 66, Num 4, pp 281-287, issn 0030-2414, 7 p.Article

En région Languedoc-Roussillon, un programme d'aide à l'arrêt du tabac pour les personnes en situation de handicapSTOEBNER-DELBARRE, A; HUTEAU, M.E; BAEZA-VELASCO, C et al.LA SANTE EN ACTION. 2013, Num 426, pp 14-16, 3 p.Article

p53 status and response to radiotherapy in rectal cancer : a prospective multilevel analysisLOPEZ-CRAPEZ, E; BIBEAU, F; THEZENAS, S et al.British journal of cancer. 2005, Vol 92, Num 12, pp 2114-2121, issn 0007-0920, 8 p.Article

Connaissances, attitudes et comportements des adultes vis-à-vis du soleil en France = Sun exposure and sun protection behavior and attitudes among the French populationSTOEBNER-DELBARRE, A; THEZENAS, S; KUNTZ, C et al.Annales de dermatologie et de vénéréologie. 2005, Vol 132, Num 8-9, pp 652-657, issn 0151-9638, 6 p., CAH1Article

Feasibility of biweekly combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in patients with metastatic solid tumors: results of a two-step phase I trial: XELIRI and XELIRINOXMAZARD, T; YCHOU, M; THEZENAS, S et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 3, pp 807-814, issn 0344-5704, 8 p.Article

Efficacy of irinotecan in combination with 5-fluorouracil (FOLFIRI) for metastatic gastric or gastroesophageal junction adenocarcinomas (MGA) treatmentSAMALIN, E; AFCHAIN, P; BOUCHE, O et al.Clinics and research in hepatology and gastroenterology (Print). 2011, Vol 35, Num 1, pp 48-54, issn 2210-7401, 7 p.Article

Impact de la TEP/TDM au ¹⁸F-FDG dans la prise en charge des patients atteints de cancer thyroïdien différencié = Role of ¹⁸F-PDG PET/CT in management of patients with differentiated thyroid cancerSIBILLE, L; GUILLEMARD, S; EBERLE-POUZERATTE, M.-C et al.Médecine nucléaire (Paris). 2010, Vol 34, Num 2, pp 78-87, issn 0928-1258, 10 p.Article

A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancerYCHOU, M; HOHENBERGER, W; THEZENAS, S et al.Annals of oncology. 2009, Vol 20, Num 12, pp 1964-1970, issn 0923-7534, 7 p.Article

A randomized phase II trial evaluating safety and efficacy of an experimental chemotherapy regimen (irinotecan + oxaliplatin, IRINOX) and two standard arms (LV5-FU2 + irinotecan or LV5-FU2 + oxaliplatin) in first-line metastatic colorectal cancer : a study of the Digestive Group of the Fédération Nationale des Centres de Lutte Contre le CancerBECOUARN, Y; SENESSE, P; THEZENAS, S et al.Annals of oncology. 2007, Vol 18, Num 12, pp 2000-2005, issn 0923-7534, 6 p.Article